Drug intelligence / Profile preview

ophiopogon decoction granules

Development stage: Preclinical
Lead developer: Yunnan Baiyao
Administration: Oral

Overview

Ophiopogon Decoction Granules (PZ-019) is a traditional Chinese medicine (TCM) formulation being developed by Yunnan Baiyao Group. It is classified as a Category 3.1 new TCM, which refers to classic prescriptions with a long history of clinical use that are being developed into modern dosage forms. The formulation is based on the "Maimendong Tang" (Ophiopogon Decoction), a classic prescription from the *Synopsis of Prescriptions of the Golden Chamber* (Jin Gui Yao Lue). It typically consists of six herbal ingredients: Ophiopogon japonicus (Maimendong), Pinellia ternata (Banxia), Oryza sativa (Gengmi), Ziziphus jujuba (Dazao), Panax ginseng (Renshen), and Glycyrrhiza uralensis (Gancao). It is traditionally used to treat "lung wilting" (lung yin deficiency) characterized by coughing, wheezing, and dry throat. Yunnan Baiyao is currently conducting IND-enabling research, focusing on process optimization for commercial-scale production.

Other names: 麦门冬汤颗粒Maimendong Tang GranulesMaimendong Decoction Granules

Beyond the preview

Go deeper on ophiopogon decoction granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ophiopogon decoction granules.

Explore the full profile